RxDoctor Payments Data

Adolph Johnson, MD

Family Medicine · Silver Spring, MDNPI 1235139387

Payments from drug & device makers

$10,746in general payments, 2019–2025

Across 593 payments — averaging $18.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • AstraZeneca$1K
  • Amgen$1K
  • Lilly USA, LLC$905
  • Novo Nordisk$819
  • GSK$622
  • plus $5K from 39 others

What the payments were for

  • Food & beverage$10,52698%
  • Education$2212%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$10,746 in reported general payments places this provider in the 90th percentile of 1,193 family medicine providers in Maryland.

See all family medicine providers in Maryland

Medicare billing

Part B allowed, 2024
$364,996
Medicare patients
390
Services billed
4,869

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin81$119,574
FarxigaDapagliflozin Propanediol67$85,867
RybelsusSemaglutide30$74,400
KerendiaFinerenone36$50,504
TrulicityDulaglutide15$43,129
JanuviaSitagliptin Phosphate23$37,502
JanumetSitagliptin Phos/Metformin Hcl23$33,031
MyrbetriqMirabegron33$32,211
MounjaroTirzepatide23$27,026
GemtesaVibegron17$19,726
OzempicSemaglutide14$18,207
XareltoRivaroxaban11$13,908
LivaloPitavastatin Calcium12$10,918
Rosuvastatin Calcium270$9,700
Celecoxib151$8,816

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$164$119,57481 claims
Novo NordiskRybelsus, Ozempic$819$92,60744 claims
AstraZenecaFarxiga$1,145$85,86767 claims
MerckJanuvia, Janumet$477$70,53346 claims
Lilly USA, LLCTrulicity, Mounjaro$905$70,15438 claims
BayerKerendia$336$50,50436 claims
Astellas Pharma US IncMyrbetriq$361$32,21133 claims
Sumitomo Pharma America, Inc.Gemtesa$196$19,72617 claims
Johnson & JohnsonXarelto$61$13,90811 claims
Kowa Pharmaceuticals America, Inc.Livalo$230$10,91812 claims
AbbVieSynthroid$1,237$5,39091 claims
PfizerPaxlovid$567$2,85930 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,193 family medicine providers in Maryland.

Other family medicine in Silver Spring

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →